FFR and iFR: Where Do We Stand Today?

Coronary Physiology: New Insights

Who Will Treat the Most Complex Patients? No Success Goes Unpunished.

Live Case & Lecture 6: Complex PCI


Provisional Stenting in Left Main vs. Non-Left Main Complex Bifurcation Stenoses: Is There a Difference?

New Concept of Bifurcation PCI

Don't Forget About Dual Pathway Inhibition: When DOAC Should NOT Be Standard Treatment

All About New Data of Antithrombotics


Bicuspid TAVR: All the Technical Issues and Data from Asan Medical Center

TAVR: Future Perspectives

The Series of FAME Studies: A Paradigm Shift in Our Thinking About Interventional Cardiology

Coronary Imaging & Physiology: Updated Concepts and Issues


Calcified Nodules in Complex PCI: Are They All the Same and How Should We Treat?

All About Tips & Tricks for Complex PCI

New Launched M-TEER Device for Degenerative Mitral Regurgitation: PASCAL Experiences in Japan

Evolution of Mitral and Tricuspid Interventions


Following BEST-CLI and BASIL-2: How to Best Serve Critical Limb Threatening Ischemia?

EVAR, TEVAR and Peripheral Interventions

AI Application of Cardiovascular Imaging

MedTech Innovation


Severe AS with Low Valve Calcium Score: Different Prognosis?

All About New Data from Asan Medical Center

Impact of Intravascular Imaging-guided PCI or CABG in Multi-Vessel Disease: The BEST Extended Follow-Up Study

All About New Data from Asan Medical Center

GE HealthCare

Rule of 5-6-7-8 for Bifurcation PCI: It Is Time to Change in 2024

New Concept of Bifurcation PCI

Timing of Complete Revascularization With Multi-Vessel PCI for AMI: Insights From the COMPLETE Trial and Future Perspectives

Left Main & Multi-Vessel PCI: Now and Future

B Braun

Moderate AS in HFrEF: Time to Treat is Now & Future Expectation from RCT

TAVR: Techniques and Issues

How Can We Further Improve Reperfusion in AMI?: Revising or Novel Approach

ACS and Acute MI: Brand New Issues

Chong Kun Dang

Revascularization for Left Main Disease: Updated Data, Global Guideline and Beyond

Left Main and Multi-Vessel Diseases: Updated Concept and Treatment

Choosing Wisely: FFR vs. Anatomy-guided Left Main PCI -The Rationale of the FATE-MAIN Trial

Left Main and Multi-Vessel Diseases: Updated Concept and Treatment


Implications of the ISCHEMIA Trial on Patient Selection for CTO-PCI

CTO-PCI: To Treat, or Not To Treat

ASSURE-DES Trial: Optimal Antiplatelet Strategy in DES Patients During Noncardiac Surgery

Ongoing Trials from Asan Medical Center


OCTIVUS Trial: OCT- vs. IVUS-guided PCI in All-comer PCI

Late-Breaking Clinical Trials 2024

PREVENT trial: Confirmative RCT of Preventive PCI for Vulnerable Plaques

Vulnerable Plaque Treatment 2024

Long-term DOAC Management of AF and Stable CAD: Expectation on the EPIC-CAD Trial After the AFIRE Trial

All About New Data of Antithrombotics

50 Years Long Journey of Coronary Physiology: From Humble To Great

TCTAP "Master of the Masters" Award 2024

DCB Use in Your PCI Practice: Adjunctive Therapy or Standard of Care?

Evolving PCI Devices: Coronary DES, BRS, and DCB

What Are Novel and Future Antithrombotic Drugs in ACS and PCI? Are There Still Unmet Needs?

Antithrombotic Hot Issues in ACS/PCI: What Are New in 2024?

TAVR-in-TAVR: The NEXT Challenging Issue in Lifetime TAVR Management

TAVR: Key Issues in 2024